Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023

1/2
Status Placed on Calendar
Sponsor Tim Scott
Citation 118-S-1852
Actions 5
Introduced Jun 7th, 2023
Cosponsors
2
Last Action Sep 6th, 2023
Policy Area
✓
Introduced Senate Jun 7
Senate
House
President
Enacted

Summary

AI Guide

What this bill does

Loading AI analysis…

Sickle Cell Disease and Other Heritable Blood Disorders Research, Surveillance, Prevention, and Treatment Act of 2023 This bill reauthorizes through FY2028 the Sickle Cell Disease Treatment Demonstration Program, which supports efforts to improve treatment and prevention of sickle cell disease and complications from that disease. (Sickle cell disease is an inherited blood disorder that can lead to pain, anemia, infections, and stroke.)

Actions

5
Senate
INTRODUCED
INTRODUCED
Jun 7, 2023
ON FLOOR
REFERRED TO COMMITTEE
COMMITTEE
COMMITTEE ORDERED TO REPORT
Jun 15, 2023
COMMITTEE
COMMITTEE REPORT FILED UNAMENDED
Sep 6, 2023
PLACED ON CALENDAR
PLACED ON CALENDAR
Version
Font size
View Source View Markdown

Cost Estimates

1

Nonpartisan fiscal analysis from the Congressional Budget Office. Click any estimate to read the full report on cbo.gov.